Magnus Walter

Magnus joined Monte Rosa Therapeutics from Abbvie Germany where he led Discovery Research focused on Alzheimer and Parkinson’s disease as Senior Director and Senior Research Fellow in Neuroscience since 2018. Prior to that Magnus held several positions at Eli Lilly where he worked for 17 years. These included Chief Scientific Officer for global Neuroscience Medicinal Chemistry and Head of Chemistry UK. Magnus started his career as team leader working for Astrazeneca after receiving his DPhil from the University of Oxford and a master’s degree in chemistry from the University of Bonn.